Posted on 1/24/2017
Six-month interim analysis of the Legflow drug-eluting balloon for the treatment of femoropopliteal occlusions (LEG-DEB) registry indicates that “the use of a new generation paclitaxel drug-coated balloon… represents a safe and effective therapeutic strategy,” according to the study investigators. Writing in the Interventional Journal of Cardiology, they note, “In this registry, as expected for this complex patient subset, the Legflow drug-coated balloon appears to be slightly less successful wh
The authors, led by Eugenio Stablie (University Federico II, Naples, Italy), write than plain balloon angioplasty can be a valuable therapeutic approach for lower limb atherosclerosis patients presenting with critical limb ischaemia or severe claudication, which may limit surgical treatment options. However, the long-term efficacy of plain balloon angioplasty is “hampere...